January
23
  10:30:01 PM

US abortions hit 30-year low

American abortions have hit their lowest level since 1976 -- 1.2 million in 2005, down from 1.3 million in 2000. According to a survey by the Guttmacher Institute, an abortion research organisation, the proportion of women ending their pregnancies with an abortion dropped 9% in the 5 years. However, neither side of the abortion debate is sure why the numbers have dropped. Putting a positive spin on the numbers, supporters emphasise the wider availability of the morning-after pill, the rapid growth in the abortion drug RU-486 and more sex education. Opponents pointed to changing attitudes and more restrictions.

Complicating the interpretation of the decline in overall numbers is the rise in the use of RU-486. Chemical abortions have been rising by 22% a year and now account for 14% of all abortions. This means that more than one in five abortions performed by the ninth week of pregnancy probably happens at home. "The impact and the promise is huge," Beth Jordan, medical director of the Association of Reproductive Health Professionals, told the Washington Post. "It's going a long way towards normalising abortion." More than half of abortion providers now offer patients the option of using RU-486, a 70% increase from the first half of 2001. ~ Washington Post, Jan 17; Washington Post, Jan 22




 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Indian surrogate for US woman dies in Gurjarat
18 May 2012
Do reproductive rights survive gender reassignment?
19 May 2012
South African activists begin euthanasia campaign
19 May 2012
70 assisted suicides in Washington state in 2011
19 May 2012
Would-be grandparents pay for their daughters’ egg freezing
19 May 2012

 Tags
research, organ trafficking, clinical trials, abortion, Canada, bioethics, genetic testing, India, suicide, informed consent, China, euthanasia, sex selection, US, assisted suicide, organ transplants, human drama, UK, law, stem cells, IVF, Down syndrome, sperm donation, organ donation, surrogacy, embryonic stem cells, commercialization, Australia, Netherlands, neuroscience,